By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Gen-Probe fell more than 2 percent in Tuesday trade after a report in The Wall Street Journal said that Novartis was no longer "actively pursuing" a deal to acquire the San Diego-based molecular diagnostics firm.

Novartis was believed to be the sole remaining bidder for Gen-Probe after Life Technologies and Thermo Fisher Scientific reportedly backed out of the bidding process.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.